Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Small cell lung cancer | R-HSA-5619066 | map05222 | alfaxalone | 1892 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | alfaxalone | 1892 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | alfaxalone | 1892 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | alfaxalone | 1892 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | alfaxalone | 1892 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | fenoterol | 3343 | drug-path |
Gap junction | R-HSA-190861 | map04540 | fenoterol | 3343 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | fenoterol | 3343 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | fenoterol | 3343 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pimethixene | 4822 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | proxymetacaine | 19493 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | proxymetacaine | 19493 | drug-path |
Hedgehog signaling pathway | R-HSA-5358351 | map04340 | proxymetacaine | 19493 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | proxymetacaine | 19493 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | proxymetacaine | 19493 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | proxymetacaine | 19493 | drug-path |
Asthma | R-HSA-444620 | map05310 | proxymetacaine | 19493 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | proxymetacaine | 19493 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | proxymetacaine | 19493 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | AG-012559 | None | drug-path |